Provided by Tiger Trade Technology Pte. Ltd.

PEIJIA-B

5.150
-0.210-3.92%
Volume:331.00K
Turnover:1.69M
Market Cap:3.48B
PE:-14.44
High:5.275
Open:5.275
Low:5.055
Close:5.360
52wk High:7.890
52wk Low:3.730
Shares:675.00M
HK Float Shares:675.00M
Volume Ratio:0.36
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.357
ROE:-7.60%
ROA:-2.20%
PB:1.62
PE(LYR):-14.44
PS:3.80

Loading ...

Beijing Strong Biotechnologies' Subsidiary Secures Multiple Medical Device Registration Certificates

Stock News
·
Mar 31

Shinva Medical Subsidiary Obtains Class II Medical Device Registration Certificate

Stock News
·
Mar 31

PEIJIA-B Maintains Outperform Rating from CICC with HK$10 Price Target

Stock News
·
Mar 30

Press Release: Peijia Medical Announces 2025 Annual Results

Dow Jones
·
Mar 26

Peijia Medical Reports Robust 2025 Performance with Steady Growth in Core Operations

Stock News
·
Mar 26

Dingzhou Regulators Conduct Training on Medical Device Distribution Regulations

Deep News
·
Mar 26

Peijia Medical Chairman Plans Up to HK$15 Million Share Purchase

MT Newswires Live
·
Mar 26

Stock Track | Peijia Medical Soars 5.28% Intraday on Strong FY2025 Results, Regulatory Approval, and CEO Share Purchase

Stock Track
·
Mar 26

BRIEF-Peijia Medical Says Increase In Shareholding By CEO

Reuters
·
Mar 26

Peijia Medical - Increase in Shareholding by CEO

THOMSON REUTERS
·
Mar 26

Peijia Medical; Chairman and CEO Yi Zhang increases stake via controlled corporation; transaction value capped at HKD 15 million

Reuters
·
Mar 26

BRIEF-Peijia Medical Says FY Loss And Total Comprehensive Expense Attributable Rmb203.3 Million

Reuters
·
Mar 25

PEIJIA-B Reports Fiscal Year Results: Revenue Up 15.82% to 713 Million Yuan, Neurointerventional Segment Profit Soars 86.6%

Stock News
·
Mar 25

Peijia Medical FY2025 segment profit for Neurointerventional Business jumps 86.6% to RMB97 million; revenue rises 15.8% to RMB713 million

Reuters
·
Mar 25

Peijia Medical FY2025; TaurusTrio TAV system wins NMPA approval for severe symptomatic aortic regurgitation; revenue rises 15.8% to CNY 713 million

Reuters
·
Mar 25

Peijia Medical FY Revenue RMB 712.9 Million

THOMSON REUTERS
·
Mar 25

Peijia Medical - 2026 Is Expected to Represent an Initial Stage of Group's Global Expansion in Neurointerventional Business

THOMSON REUTERS
·
Mar 25

NT PHARMA Finalizes Acquisition of Majority Stake in Zhejiang Kangyuan Medical Equipment

Stock News
·
Mar 25

Two Innovative Medical Device Firms File for IPO on Shanghai's STAR Market

Deep News
·
Mar 24